Verekitug

DRUG2 trials

Sponsors

Upstream Bio Inc.

Conditions

Chronic Obstructive Pulmonary DiseaseSevere Asthma

Phase 2

A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)

Active, not recruitingNCT06966479

Upstream Bio Inc.Severe Asthma

Start: 2025-05-21End: 2027-09-01Updated: 2026-05-14

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

Active, not recruitingNCT06981078

Upstream Bio Inc.Chronic Obstructive Pulmonary Disease

Start: 2025-07-02End: 2027-11-01Target: 666Updated: 2026-07-20